CSIMarket


Century Therapeutics inc   (IPSC)
Other Ticker:  
 

Century Therapeutics inc

IPSC's Fundamental analysis








Looking into Century Therapeutics Inc growth rates, revenue grew by 434.46 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 2248

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 15.85 %

Century Therapeutics Inc net loss decreased from $-33 millions, to $-31 millions in III. Quarter 2024,

More on IPSC's Growth


Century Therapeutics Inc
realized a net loss in trailing twelve months.

Century Therapeutics Inc realized cash reduction of $ -0.02 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 46.37.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.88.


More on IPSC's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 35,800
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 1.86

Century Therapeutics Inc
realized net loss in trailing twelve months.

Century Therapeutics Inc realized cash outflow of $ -0.02per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 46.37.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.88.

Century Therapeutics Inc Price to Book Ratio is at 0.64 lower than Industry Avg. of 1787.7. and higher than S&P 500 Avg. of 0

More on IPSC's Valuation

  Market Capitalization (Millions $) 125
  Shares Outstanding (Millions) 85
  Employees 75
  Revenues (TTM) (Millions $) 3
  Net Income (TTM) (Millions $) -130
  Cash Flow (TTM) (Millions $) -2
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 35,800
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 1.86

  Market Capitalization (Millions $) 125
  Shares Outstanding (Millions) 85
  Employees 75
  Revenues (TTM) (Millions $) 3
  Net Income (TTM) (Millions $) -130
  Cash Flow (TTM) (Millions $) -2
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 10.39
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 1.23
  Asset Turnover Ratio (TTM) 0.01
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com